Cargando…

Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis

To examine the relationship between cytotoxic T lymphocyte antigen 4 (CTLA-4) expression and breast cancer prognosis, CTLA-4 expression was immunohistochemically detected in paraffin-embedded specimens of primary tumors from 130 patients with breast cancer who had a mean follow-up period of 112 mont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Haiming, Yang, Junlan, Jiao, Shunchang, Li, Ying, Zhang, Wei, Wang, Jiandong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481300/ https://www.ncbi.nlm.nih.gov/pubmed/25893809 http://dx.doi.org/10.1007/s00262-015-1696-2

Ejemplares similares

Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis
por: Zhang, Xiao-Fei, et al.
Publicado: (2016)

The prognostic value of cytotoxic T-lymphocyte antigen 4 in cancers: a systematic review and meta-analysis
por: Hu, Pingping, et al.
Publicado: (2017)

Expression of cytotoxic T lymphocyte-associated antigen 4, CD44, and E-cadherin in the microenvironment of breast carcinomas
por: Savli, Tugce Bolme, et al.
Publicado: (2023)

Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy
por: Liu, Qiqi, et al.
Publicado: (2017)

Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma
por: Tosti, Giulio, et al.
Publicado: (2013)

The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis
por: Basile, Maria Sofia, et al.
Publicado: (2022)

Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer
por: Zhu, Yanyun, et al.
Publicado: (2016)

Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma
por: Liu, Jiajia, et al.
Publicado: (2021)

Antigen presentation to cytotoxic T lymphocytes in vivo
Publicado: (1995)

The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab, in the treatment of melanoma
por: Verschraegen, Claire
Publicado: (2012)

Cytotoxic T lymphocyte antigen 4 polymorphism 49 (A→G) and migraine
por: Lulli, P., et al.
Publicado: (2005)

Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors
por: Zhu, Yanyun, et al.
Publicado: (2013)

Cytotoxic T-Lymphocyte Associated Antigen 4 Polymorphisms and Asthma Risk: A Meta-Analysis
por: Nie, Wei, et al.
Publicado: (2012)

Antigen receptor-regulated exocytosis in cytotoxic T lymphocytes
Publicado: (1987)

Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes
por: Lühder, Fred, et al.
Publicado: (1998)

Higher human lymphocyte antigen class I expression in early‐stage cancer cells leads to high sensitivity for cytotoxic T lymphocytes
por: Akazawa, Yu, et al.
Publicado: (2019)

Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine
por: Derakhshani, Afshin, et al.
Publicado: (2021)

Breast carcinoma with choriocarcinomatous features: a case report and review of the literature
por: Zhu, Yanyun, et al.
Publicado: (2014)

Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas
por: Kassardjian, Ari, et al.
Publicado: (2018)

Cytotoxic T Lymphocyte Antigen 4 and CD28 Modulate Cell Surface Raft Expression in Their Regulation of T Cell Function
por: Martin, Margarita, et al.
Publicado: (2001)

Induction of Cytotoxic T Lymphocyte Antigen 4 (Ctla-4) Restricts Clonal Expansion of Helper T Cells
por: Doyle, Alden M., et al.
Publicado: (2001)

Herpesvirus entry mediator as a potential biomarker in breast cancer compared with conventional cytotoxic T‑lymphocyte‑associated antigen 4
por: Aldahlawi, Alia, et al.
Publicado: (2023)

Proceedings: Lymphocyte dependent cytotoxic antibody activity against human melanoma antigens.
por: Vanwijck, R., et al.
Publicado: (1974)

Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes
por: Wang, Rong-Fu, et al.
Publicado: (1996)

Genetic Polymorphisms of Cytotoxic T-Lymphocyte Antigen 4 in Primary Biliary Cholangitis: A Meta-Analysis
por: Yang, Xing-Chen, et al.
Publicado: (2017)

Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens
Publicado: (1985)

Concanavalin A-mediated activation of antigen-primed lymphocytes into secondary cytotoxic lymphocytes
Publicado: (1977)

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes
por: Rollinghoff, M, et al.
Publicado: (1977)

Modulation of Susceptibility to HIV-1 Infection by the Cytotoxic T Lymphocyte Antigen 4 Costimulatory Molecule
por: Riley, James L., et al.
Publicado: (2000)

A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment
por: LI, MINGYUE, et al.
Publicado: (2016)

Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseases
por: Brunner-Weinzierl, Monika C, et al.
Publicado: (2004)

Ubiquitin specific protease 21 upregulation in breast cancer promotes cell tumorigenic capability and is associated with the NOD-like receptor signaling pathway
por: Peng, Liang, et al.
Publicado: (2016)

Expression and Prognosis of Sperm-Associated Antigen 1 in Human Breast Cancer
por: Lin, Shuangyan, et al.
Publicado: (2021)

Association among cytotoxic T-lymphocyte antigen 4 gene, rs231775 polymorphism, and recurrent pregnancy loss risk
por: Song, Yonghui, et al.
Publicado: (2019)

Rigid-body Ligand Recognition Drives Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Receptor Triggering
por: Yu, Chao, et al.
Publicado: (2011)

Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and Thyroglobulin (TG) Genetic Variants with Autoimmune Hypothyroidism
por: Patel, Hinal, et al.
Publicado: (2016)

Current Understanding of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Signaling in T-Cell Biology and Disease Therapy
por: Kim, Gil-Ran, et al.
Publicado: (2022)

Immunologic Self-Tolerance Maintained by Cd25(+)Cd4(+)Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4
por: Takahashi, Takeshi, et al.
Publicado: (2000)

Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment
por: Sconocchia, Giuseppe, et al.
Publicado: (2022)

Effect of Cytotoxic T-Lymphocyte Antigen-4 on the Efficacy of the Fatty Acid-Binding Protein Vaccine Against Schistosoma japonicum
por: Tang, Chun-lian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gn6fislfhvtagh3ea5r7v1sjj4